The deal size was increased to $300M from $175M and priced below last closing price of $19.39. Morgan Stanley, JPMorgan, Jefferies and Stifel are acting as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DYN:
- Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
- Dyne Therapeutics Announces Proposed Public Offering of Common Stock
- Dyne Therapeutics announces $175M common stock offering
- Dyne data validate Avidity Biosciences study, says Wells Fargo
- Dyne Therapeutics price target raised to $56 from $27 at Raymond James
